106 records matched your query       

01410aam a2200337Ia 4500
001 B17B0B80FE5F11E2B6A414D3DAD10320
003 SILO
005 20130806010419
006 m        d f      
007 cr an|||||||||
008 100322s2003    mdu     sb   f000 0 eng d
035    $a (OCoLC)565949861
040    $a GPO $c GPO $d MvI $d SILO
043    $a n-us---
074    $a 0499-T (online)
086 0  $a HE 20.4702:IN 8/4
245 00 $a Guidance for industry $h [electronic resource] : $b INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information.
246 30 $a INDs for phase 2 and phase 3 studies, chemistry, manufacturing, and controls information
260    $a [Rockville, MD] : $b U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, $c [2003]
300    $a 1 electronic resource (24 p.)
500    $a "CMC."
500    $a "May 2003."
504    $a Includes bibliographical references (p. 23-24).
650  0 $a Medicine, Experimental $x Government policy $z United States.
650  0 $a Drug approval $z United States.
710 2  $a Center for Drug Evaluation and Research (U.S.)
856 40 $u http://purl.access.gpo.gov/GPO/LPS120770
941    $a 2
952    $l UPAX334 $d 20230104042325.0
952    $l USUX851 $d 20160825054925.0
956    $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=B17B0B80FE5F11E2B6A414D3DAD10320